検索キーワード： バイオテクノロジー

疲労することが恥とされてきた欧米では、疲労の研究はタブーとされ、結果として、日本が世界の疲労研究をリードしてきた。しかしいま、うつ病や新型コロナ後遺症によって、疲労は世界共通の大問題となってきた！

・「自律神経のバランスが乱れている」ってどういうこと？・皮膚を刺激すると自律神経の活動が変わる？・瞳を見て、自律神経の活動を確認する方法

ヒトはウイルスと共に生きている。私たちのからだは一見きれいに見えても実はウイルスまみれだった！免疫学者とウイルス学者がタッグを組んで生命科学最大のフロンティアを一望！

アメリカの研究者が確認！STAP細胞は本当に存在した！マスコミ総がかりでリンチしたSTAP細胞騒動の闇と光

ウイルス学者は、ウイルスを作り出すことができます。感染細胞から、ウイルスのタンパク質の設計図が書いてあるDNAをとってきて、それをプラスミドという大腸菌内の環状DNAに入れて増殖させるのです。

Microfluidics is the field of science that studies fluids constrained to spaces that are smaller than one millimeter wide, and by extension, the engineering field which builds devices that exploit the unique properties of fluids at these scales. Author Albert Folch explores this micro science which has inspired engineers to build devices such as engines, spray cans, ballpoint pens, inkjet and 3D printers, pregnancy and Covid tests, glucometers, asthma nebulizers, kidney dialysis machines, and DNA analyzers.

Since it was first published in 2005, Ray Kurzweil's The Singularity Is Near and its vision of the future have been influential in spawning a worldwide movement with millions of followers, hundreds of books, major films, and thousands of articles. During the succeeding decade, many of Kurzweil's predictions about technological advancements have been borne out, and their viability has become familiar to the public through such now commonplace concepts. In this entirely new book Ray Kurzweil brings a fresh perspective to advances in the singularity.

The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar start-up, by the prize-winning journalist who first broke the story and pursued it to the end. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose start-up ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier.

Dr. Topol’s unprecedented, evidenced-based guide is about how you and your family and friends can benefit from new treatments coming available at a faster rate than ever. From his unique position as a leader overseeing millions in research funding, Dr. Topol also explains the fundamental reasons—from semaglutides to AI—that we can be confident these breakthroughs will continue. Ninety-five percent of Americans over sixty have at least one chronic disease and almost as many have two. That is the essential problem this revolution is solving.

「進化は再現不可能な一度限りの現象なのか？　それとも同じような環境条件では同じような適応が繰り返し発生するのか？」進化のあり方をめぐって、進化生物学者の間で20世紀から大論争を繰り広げられてきた命題をめぐるサイエンスミステリー。

For over three decades, Ray Kurzweil has been one of the most respected and provocative advocates of the role of technology in our future. In his classic The Age of Spiritual Machines, he argued that computers would soon rival the full range of human intelligence at its best. Now he examines the next step in this inexorable evolutionary process: The union of human and machine, in which the knowledge and skills embedded in our brains will be combined with the vastly greater capacity, speed, and knowledge-sharing ability of our creations.

James D. Watson, the Nobel laureate whose pioneering work helped unlock the mystery of DNA's structure, charts the greatest scientific journey of our time, from the discovery of the double helix to today's controversies to what the future may hold. Updated to include new findings in gene editing, epigenetics, and agricultural chemistry as well as two entirely new chapters on personal genomics and cancer research. This is the most comprehensive and authoritative exploration of DNA's impact on our society and our world.

Vaccines: Mythology, Ideology, and Reality tells the story of this technology and the celebrated men who developed it with some success, but also with failures that are never mentioned in the celebratory literature on vaccines. Vaccine advocates often proclaim that they “follow the science,” but most vaccine development has been a matter of guesses, gambles, and wild experimentation. Its key figures have been biased by religious faith, wishful thinking, ideology, and a desire for recognition and money.

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

生物は、なぜ進化するのか？　生命40億年の冒険が始まる！なぜウマの指は1本になった？獲得した形質の遺伝は存在する？「共通祖先」は地球最初の生物ではない？

We are about to cross a critical threshold in the history of our species. Everything is about to change. Soon we will live surrounded by AIs. They will carry out complex tasks-operating businesses, producing unlimited digital content, running core government services and maintaining infrastructure. This will be a world of DNA printers and quantum computers, engineered pathogens and autonomous weapons, robot assistants and abundant energy. It represents nothing less than a step change in human capability. We are not prepared.

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

In the popular imagination, superhuman artificial intelligence is an approaching tidal wave that threatens not just jobs and human relationships, but civilization itself. Conflict between humans and machines is seen as inevitable and its outcome all too predictable. In this groundbreaking audiobook, distinguished AI researcher Stuart Russell argues that this scenario can be avoided, but only if we rethink AI from the ground up. Russell begins by exploring the idea of intelligence in humans and in machines.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

This audiobook, Tomorrow's Medicine, looks at some of the more fascinating areas where technology that could transform health is being developed, including cybernetics, regenerative medicine, nanotechnology, and genetically tailored treatments. Although many of these advances may not be ready to treat humans for many years, some of them may someday profoundly change - and extend - our lives. As exciting as the possibilities are to extend both the length and quality of life, immortality - or at least agelessness - may be forever out of our reach.